Overview

A Multicentre, Double-Blind, Double-Dummy, Randomised Study of the Analgesic Efficacy and Safety of Valdecoxib Compared to Diclofenac Sodium in Patients Undergoing Knee Arthroscopy for Anterior Cruciate Ligament (ACL) Reconstruction

Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
0
Participant gender:
All
Summary
To demonstrate non-inferiority of valdecoxib 20 mg twice daily (BID) (with an initial loading dose of 40 mg followed by a second dose of 20 mg on the first day only) with diclofenac sodium delayed release 75 mg BID in analgesic efficacy, in subjects undergoing knee arthroscopy procedure for anterior cruciate ligament (ACL) reconstruction, when administered for 6 (±1) days.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Pfizer
Treatments:
Analgesics
Diclofenac
Valdecoxib
Criteria
Inclusion Criteria:

- Patients who had undergone an uncomplicated ACL reconstruction procedure and were in
satisfactory health were included in the study

- In addition, they needed to have a baseline pain intensity of ≥ 50 mm on the VAS and
"moderate to severe" pain on the categorical scale within 8 hours of the completion of
the surgical procedure to be included

Exclusion Criteria:

- Patient was scheduled to undergo any other surgical procedure, along with the
orthopedic procedure, that was expected to produce a greater degree of surgical trauma
than the orthopedic procedure alone

- The patient was undergoing bilateral knee arthroscopy

- The patient used conventional NSAIDs, COX-2 inhibitors, or Tramadol during the 6 hours
preceding surgery, during surgery or subsequent to the end of surgery, until
randomization

- The patient received oxaprozin or piroxicam within one week prior to randomization

- The patient was required to take muscle relaxants, tricyclic antidepressants,
tranquilizers, sedatives, hypnotics and neuroleptics, in the post operative period
after the patient was randomized into the study

- The patient had been treated with patient controlled analgesia subsequent to the end
of the surgical procedure